BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20928976)

  • 1. [Fifty years studying hiperlipidemias: the case of familial combined hyperlipidemia].
    Aguilar-Salinas C; Gómez-Díaz R; Tusié-Luna MT
    Invest Clin; 2010 Jun; 51(2):145-58. PubMed ID: 20928976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial combined hyperlipidemia: controversial aspects of its diagnosis and pathogenesis.
    Aguilar Salinas CA; Zamora M; Gómez-Díaz RA; Mehta R; Gómez Pérez FJ; Rull JA
    Semin Vasc Med; 2004 May; 4(2):203-9. PubMed ID: 15478042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abdominal obesity and expression of familial combined hyperlipidemia.
    van der Kallen CJ; Voors-Pette C; de Bruin TW
    Obes Res; 2004 Dec; 12(12):2054-61. PubMed ID: 15687407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative trait loci for apolipoprotein B, cholesterol, and triglycerides in familial combined hyperlipidemia pedigrees.
    Cantor RM; de Bruin T; Kono N; Napier S; van Nas A; Allayee H; Lusis AJ
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1935-41. PubMed ID: 15308552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic dissection of familial combined hyperlipidemia.
    Eurlings PM; van der Kallen CJ; Geurts JM; van Greevenbroek MM; de Bruin TW
    Mol Genet Metab; 2001; 74(1-2):98-104. PubMed ID: 11592807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAMILIAL COMBINED HYPERLIPIDEMIA: CURRENT KNOWLEDGE, PERSPECTIVES, AND CONTROVERSIES.
    Bello-Chavolla OY; Kuri-García A; Ríos-Ríos M; Vargas-Vázquez A; Cortés-Arroyo JE; Tapia-González G; Cruz-Bautista I; Aguilar-Salinas CA
    Rev Invest Clin; 2018; 70(5):224-236. PubMed ID: 30307446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling the complex genetics of familial combined hyperlipidemia.
    Suviolahti E; Lilja HE; Pajukanta P
    Ann Med; 2006; 38(5):337-51. PubMed ID: 16938803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia.
    Ayyobi AF; McGladdery SH; McNeely MJ; Austin MA; Motulsky AG; Brunzell JD
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1289-94. PubMed ID: 12750118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1).
    Pajukanta P; Lilja HE; Sinsheimer JS; Cantor RM; Lusis AJ; Gentile M; Duan XJ; Soro-Paavonen A; Naukkarinen J; Saarela J; Laakso M; Ehnholm C; Taskinen MR; Peltonen L
    Nat Genet; 2004 Apr; 36(4):371-6. PubMed ID: 14991056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of familial combined hyperlipidemia.
    Naukkarinen J; Ehnholm C; Peltonen L
    Curr Opin Lipidol; 2006 Jun; 17(3):285-90. PubMed ID: 16680034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia.
    Reynisdottir S; Eriksson M; Angelin B; Arner P
    J Clin Invest; 1995 May; 95(5):2161-9. PubMed ID: 7738184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Familial combined hyperlipidemia].
    Sasaki J
    Nihon Rinsho; 1999 Dec; 57(12):2776-81. PubMed ID: 10638212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biochemical diagnosis of hereditary hyperlipoproteinemias].
    Tvorogova MG; Rozhkova TA; Alidzhanova KhG; Semenova OA; Sobolev AV; Kukharchuk VV; Titov VN
    Ter Arkh; 1998; 70(4):9-15. PubMed ID: 9612894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parabolic relationship between plasma triacylglycerols and LDL-cholesterol in familial combined hyperlipidaemia: the multiple-type hyperlipidaemia explained?
    Brouwers MC; de Graaf J; van Greevenbroek MM; Georgieva AM; van der Kallen CJ; Ter Avest E; Stehouwer CD; Stalenhoef AF; de Bruin TW
    Clin Sci (Lond); 2008 Mar; 114(5):393-401. PubMed ID: 17953518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia.
    Nohara A; Kawashiri MA; Claudel T; Mizuno M; Tsuchida M; Takata M; Katsuda S; Miwa K; Inazu A; Kuipers F; Kobayashi J; Koizumi J; Yamagishi M; Mabuchi H
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):923-8. PubMed ID: 17272748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype at a major locus with large effects on apolipoprotein B levels predicts familial combined hyperlipidemia.
    Jarvik GP; Beaty TH; Gallagher PR; Coates PM; Cortner JA
    Genet Epidemiol; 1993; 10(4):257-70. PubMed ID: 8224806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of chromosome 1q21-q23 to familial combined hyperlipidemia in Mexican families.
    Huertas-Vázquez A; del Rincón JP; Canizales-Quinteros S; Riba L; Vega-Hernández G; Ramírez-Jiménez S; Aurón-Gómez M; Gómez-Pérez FJ; Aguilar-Salinas CA; Tusié-Luna MT
    Ann Hum Genet; 2004 Sep; 68(Pt 5):419-27. PubMed ID: 15469419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic criteria in relation to the pathogenesis of familial combined hyperlipidemia.
    de Graaf J; van der Vleuten G; Stalenhoef AF
    Semin Vasc Med; 2004 Aug; 4(3):229-40. PubMed ID: 15630632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An association of apolipoprotein B with pulse pressure in Chinese pedigrees with familial combined hyperlipidemia].
    Pei WD; Sun YH; Zhang J; Liu Q; Jing ZC; Qiu DY; Liu YH; Gong J; Feng TJ; Lu ZL; Hui RT; Wu XG; Liu LS
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):380-3. PubMed ID: 15061989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of severe, resistant familial combined hyperlipidemia with a bezafibrate-lovastatin combination.
    Yeshurun D; Abukarshin R; Elias N; Lanir A; Naschitz JE
    Clin Ther; 1993; 15(2):355-63. PubMed ID: 8519043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.